blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2429299

EP2429299 - TREATING MALE INFERTILITY SECONDARY TO SPERM OXIDATIVE STRESS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.04.2017
Database last updated on 26.07.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR
published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
CELLOXESS LLC
15 Roszel Road
Princeton, NJ 08540 / US
[2016/22]
Former [2012/30]For all designated states
CELLOXESS LLC
16 Blue Spruce Drive
Pennington NJ 08534-2109 / US
Former [2012/12]For all designated states
Gharagozloo, Parviz
16 Blue Spruce Drive
Pennington, NJ 08534 / US
Inventor(s)01 / GHARAGOZLOO, Parviz
15 Roszel Road
Princeton NJ 08540 / US
 [2016/21]
Former [2012/12]01 / see applicant
...
Representative(s)Bingham, Ian Mark
The IP Asset Partnership Limited
Prama House
267 Banbury Road
Oxford OX2 7HT / GB
[2016/22]
Former [2012/12]Bingham, Ian Mark
IP Asset LLP
Prama House
267 Banbury Road
Oxford
OX2 7HT / GB
Application number, filing date10770451.230.04.2010
[2016/22]
WO2010US33251
Priority number, dateUS20090174732P01.05.2009         Original published format: US 174732 P
[2012/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010127297
Date:04.11.2010
Language:EN
[2010/44]
Type: A1 Application with search report 
No.:EP2429299
Date:21.03.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 04.11.2010 takes the place of the publication of the European patent application.
[2012/12]
Type: B1 Patent specification 
No.:EP2429299
Date:01.06.2016
Language:EN
[2016/22]
Search report(s)International search report - published on:US04.11.2010
(Supplementary) European search report - dispatched on:EP02.07.2013
ClassificationIPC:A01N59/16, A61K31/01, A61K31/221, A61K31/355, A61K31/375, A61K31/385, A61K31/519, A61K33/04, A61K33/06, A61K33/30, A61K45/06, A61P15/10
[2013/31]
CPC:
A61K33/30 (EP,US); A61K31/01 (EP,US); A61K31/221 (EP,US);
A61K31/355 (EP,US); A61K31/375 (EP,US); A61K31/385 (EP,US);
A61K31/519 (EP,US); A61K33/04 (EP,US); A61K33/06 (EP,US);
A61K45/06 (EP,US); A61P15/08 (EP); A61P15/10 (EP) (-)
C-Set:
A61K31/01, A61K2300/00 (US,EP);
A61K31/221, A61K2300/00 (US,EP);
A61K31/355, A61K2300/00 (US,EP);
A61K31/375, A61K2300/00 (US,EP);
A61K31/385, A61K2300/00 (EP,US);
A61K33/04, A61K2300/00 (EP,US);
A61K33/06, A61K2300/00 (EP,US);
A61K33/30, A61K2300/00 (EP,US)
(-)
Former IPC [2012/12]A01N59/16
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/12]
Extension statesALNot yet paid
BANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:BEHANDLUNG MÄNNLICHER UNFRUCHTBARKEIT NACH OXIDATIVEM STRESS DER SPERMIEN[2012/12]
English:TREATING MALE INFERTILITY SECONDARY TO SPERM OXIDATIVE STRESS[2012/12]
French:TRAITEMENT DE LA STÉRILITÉ MÂLE CONSÉCUTIVE À UN STRESS OXYDATIF DU SPERME[2012/12]
Entry into regional phase29.11.2011National basic fee paid 
29.11.2011Search fee paid 
29.11.2011Designation fee(s) paid 
29.11.2011Examination fee paid 
Examination procedure29.11.2011Examination requested  [2012/12]
17.01.2014Amendment by applicant (claims and/or description)
15.06.2015Despatch of a communication from the examining division (Time limit: M06)
08.12.2015Reply to a communication from the examining division
15.01.2016Communication of intention to grant the patent
18.04.2016Fee for grant paid
18.04.2016Fee for publishing/printing paid
18.04.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.06.2015
Opposition(s)02.03.2017No opposition filed within time limit [2017/19]
Fees paidRenewal fee
14.03.2012Renewal fee patent year 03
07.03.2013Renewal fee patent year 04
25.03.2014Renewal fee patent year 05
11.04.2015Renewal fee patent year 06
02.03.2016Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.04.2010
AT01.06.2016
BE01.06.2016
BG01.06.2016
CY01.06.2016
CZ01.06.2016
DK01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
MC01.06.2016
MK01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SI01.06.2016
SK01.06.2016
SM01.06.2016
TR01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
[2020/15]
Former [2019/51]HU30.04.2010
AT01.06.2016
BE01.06.2016
BG01.06.2016
CY01.06.2016
CZ01.06.2016
DK01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
MC01.06.2016
MK01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SI01.06.2016
SK01.06.2016
SM01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
Former [2019/46]HU30.04.2010
AT01.06.2016
BE01.06.2016
BG01.06.2016
CY01.06.2016
CZ01.06.2016
DK01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
MC01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SI01.06.2016
SK01.06.2016
SM01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
Former [2019/39]HU30.04.2010
AT01.06.2016
BE01.06.2016
BG01.06.2016
CZ01.06.2016
DK01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
MC01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SI01.06.2016
SK01.06.2016
SM01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
Former [2019/31]HU30.04.2010
AT01.06.2016
BE01.06.2016
CZ01.06.2016
DK01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
MC01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SI01.06.2016
SK01.06.2016
SM01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
Former [2018/06]AT01.06.2016
BE01.06.2016
CZ01.06.2016
DK01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
MC01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SI01.06.2016
SK01.06.2016
SM01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
Former [2017/37]AT01.06.2016
BE01.06.2016
CZ01.06.2016
DK01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SI01.06.2016
SK01.06.2016
SM01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
Former [2017/11]AT01.06.2016
BE01.06.2016
CZ01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SK01.06.2016
SM01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
PT03.10.2016
Former [2017/10]BE01.06.2016
CZ01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
NL01.06.2016
PL01.06.2016
RO01.06.2016
SE01.06.2016
SK01.06.2016
NO01.09.2016
GR02.09.2016
IS01.10.2016
Former [2017/09]CZ01.06.2016
EE01.06.2016
FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
NL01.06.2016
RO01.06.2016
SE01.06.2016
NO01.09.2016
GR02.09.2016
Former [2016/52]FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
NL01.06.2016
SE01.06.2016
NO01.09.2016
GR02.09.2016
Former [2016/51]FI01.06.2016
HR01.06.2016
LT01.06.2016
LV01.06.2016
NO01.09.2016
GR02.09.2016
Former [2016/49]FI01.06.2016
LT01.06.2016
NO01.09.2016
Former [2016/46]LT01.06.2016
NO01.09.2016
Documents cited:Search[X]WO0164203  (SIGMA TAU HEALTHSCIENCE SPA [IT], et al) [X] 1,4,6,10 * page 15; examples 5,6 *;
 [I]US2002142052  (TRANT AILEEN SONTAG [US]) [I] 1-18 * page 1, column 1 - column 2; claims 1-16 *;
 [A]  - FREY K A ET AL, "The clinical content of preconception care: preconception care for men", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, vol. 199, no. 6, doi:10.1016/J.AJOG.2008.10.024, ISSN 0002-9378, (20081201), pages S389 - S395, (20081209), XP025760368 [A] 1-18 * page S392, column 1, paragraph 1 - paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.ajog.2008.10.024
International search[Y]US2009081177  (TREMELLEN KELTON PAUL [AU]);
 [Y]  - AGARWAL, "Role of Oxidative Stress in Male Infer tility and Antioxidant Supplementation", CLEVELANDCLINIC, BUSINESS BRIEFING: US KIDNEY & UROLOGICAL DISEASE, (20050601), URL: http://www.clevelandclinic.org/reproductiveresearchcenter/docs/agradoc174.pdf, (20100615), XP008150825
 [A]  - AGARWAL ET AL., "Prevention of Oxidative Stress Injury to Sperm", JOURNAL OF ANDROLOGY, (20051101), vol. 26, no. 6, pages 654 - 660, XP008150617

DOI:   http://dx.doi.org/10.2164/jandrol.05016
by applicantUS4808616
 US4876045
 US4904650
 WO03084526
    - GOMEZ ET AL., INTERNATIONAL JOURNAL OF ANDROLOGY, (1998), vol. 21, no. 2, pages 81 - 96
    - AGARWAL ET AL., "Role of Antioxidants in Treatment of Male Infertility: an Overview of the Literature", REPRODUCTIVE BIOMEDICINE ONLINE, (2004), vol. 8, no. 6, pages 616 - 62
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.